DE69722557D1 - Verwendung von Sericin als Antioxidantien und Tyrosinase-Inhibitoren - Google Patents

Verwendung von Sericin als Antioxidantien und Tyrosinase-Inhibitoren

Info

Publication number
DE69722557D1
DE69722557D1 DE69722557T DE69722557T DE69722557D1 DE 69722557 D1 DE69722557 D1 DE 69722557D1 DE 69722557 T DE69722557 T DE 69722557T DE 69722557 T DE69722557 T DE 69722557T DE 69722557 D1 DE69722557 D1 DE 69722557D1
Authority
DE
Germany
Prior art keywords
sericin
antioxidants
tyrosinase activity
tyrosinase inhibitors
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69722557T
Other languages
English (en)
Other versions
DE69722557T2 (de
Inventor
Hideyuki Yamada
Naozumi Fuwa
Masakazu Nomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seiren Co Ltd
Original Assignee
Seiren Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP29601596A external-priority patent/JP3610358B2/ja
Priority claimed from JP9069416A external-priority patent/JPH10265403A/ja
Application filed by Seiren Co Ltd filed Critical Seiren Co Ltd
Application granted granted Critical
Publication of DE69722557D1 publication Critical patent/DE69722557D1/de
Publication of DE69722557T2 publication Critical patent/DE69722557T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/41Retaining or modifying natural colour by use of additives, e.g. optical brighteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/42Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69722557T 1996-11-08 1997-11-07 Verwendung von Sericin als Antioxidantien und Tyrosinase-Inhibitoren Expired - Lifetime DE69722557T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29601596 1996-11-08
JP29601596A JP3610358B2 (ja) 1996-11-08 1996-11-08 抗酸化剤
JP6941697 1997-03-24
JP9069416A JPH10265403A (ja) 1997-03-24 1997-03-24 チロシナーゼ活性阻害剤

Publications (2)

Publication Number Publication Date
DE69722557D1 true DE69722557D1 (de) 2003-07-10
DE69722557T2 DE69722557T2 (de) 2004-05-06

Family

ID=26410620

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722557T Expired - Lifetime DE69722557T2 (de) 1996-11-08 1997-11-07 Verwendung von Sericin als Antioxidantien und Tyrosinase-Inhibitoren

Country Status (7)

Country Link
US (1) US6165982A (de)
EP (1) EP0841065B1 (de)
KR (1) KR100478928B1 (de)
AT (1) ATE242000T1 (de)
DE (1) DE69722557T2 (de)
ES (1) ES2201249T3 (de)
HK (1) HK1005932A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6497893B1 (en) * 1999-06-30 2002-12-24 Kimberly-Clark Worldwide, Inc. Silk protein treatment composition and treated substrate for transfer to skin
KR100338684B1 (ko) * 1999-02-26 2002-05-30 정찬복 세리신의 추출방법 및 그 용도
CN1168493C (zh) * 1999-03-04 2004-09-29 精炼株式会社 功能性口服剂
US6506394B1 (en) 1999-06-30 2003-01-14 Kimberly-Clark Worldwide, Inc. Delivery of a botanical extract to a treated substrate for transfer to skin
US6500443B1 (en) 1999-06-30 2002-12-31 Kimberly-Clark Worldwide, Inc. Delivery of a sacrificial substrate to inhibit protease permeation into skin
US6503524B1 (en) 2000-06-16 2003-01-07 Kimberly-Clark Worldwide, Inc. Delivery of a skin health benefit agent to a treated substrate for transfer to skin
KR100462805B1 (ko) * 2002-03-06 2004-12-29 재단법인서울대학교산학협력재단 세리신의 효소가수분해방법 및 그에 사용되는 반응기
AU2003261730A1 (en) * 2002-08-29 2004-03-19 Hayashibara, Ken Antiallergic agent
WO2005032505A1 (de) * 2003-09-22 2005-04-14 Juvena (International) Ag Haut- und haarpflegezubereitung enthaltend eine kombination aus proteinhydrolysaten
KR100676682B1 (ko) 2005-02-03 2007-02-02 주식회사 뉴트렉스테크놀러지 피부 건조화로 인한 질환을 예방, 치료하는 약학 조성물
US20090269825A1 (en) * 2005-11-11 2009-10-29 Toyo Boseki Kabushiki Kaisha Method for stabilization of biological molecule and composition
US20080070982A1 (en) * 2006-09-15 2008-03-20 Graham Timmins System and methods of melanoma prevention
JP2010018522A (ja) 2007-03-23 2010-01-28 Hiroshima Univ アディポネクチン産生促進剤
CA2728140C (en) 2007-06-27 2019-09-03 The Board Of Trustees Of The Leland Stanford Junior University Peptide tyrosinase inhibitors and uses thereof
CN104083752B (zh) * 2007-06-27 2018-04-10 里兰斯坦福初级大学理事会 寡肽酪氨酸酶抑制剂及其应用
KR100978311B1 (ko) * 2008-01-04 2010-08-26 한국원자력연구원 방사선 조사에 의하여 항산화능과 티로시나제 저해능이증가된 세리신, 그의 제조방법 및 그의 사용방법
EP2609927A4 (de) 2010-08-27 2014-02-26 Yakult Honsha Kk Zellschutzmittel
IT1402867B1 (it) * 2010-11-10 2013-09-27 Stazione Sperimentale Per La Seta Preparazioni dermatologiche e/o cosmetiche ad attivita' antitirosinasica, antiossidante, antielastasica ed anticollagenasica
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
WO2014059008A1 (en) 2012-10-09 2014-04-17 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
CN111278421B (zh) 2017-10-25 2022-12-09 联合利华知识产权控股有限公司 包含结构化水相和丝胶蛋白的组合物
WO2019101524A1 (en) * 2017-11-21 2019-05-31 Unilever N.V. A personal care composition comprising sericin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3233388C2 (de) * 1982-09-09 1988-06-16 Beiersdorf Ag, 2000 Hamburg Verwendung von Sericin in haarkosmetischen Mitteln und Badezusatzpräparaten
DE3408406A1 (de) * 1984-03-08 1985-09-12 Beiersdorf Ag, 2000 Hamburg Licht- und sonnenschutzmittel
DE3603595A1 (de) * 1986-02-06 1987-08-13 Beiersdorf Ag Haarkosmetische mittel
FR2698869B1 (fr) * 1992-12-09 1995-02-24 Morelle Jean Acylaminoacides obtenus à partir de fibres issues du Bombyx Mori.

Also Published As

Publication number Publication date
HK1005932A1 (en) 1999-02-05
EP0841065A3 (de) 1999-04-21
DE69722557T2 (de) 2004-05-06
KR19980042150A (ko) 1998-08-17
EP0841065B1 (de) 2003-06-04
ES2201249T3 (es) 2004-03-16
KR100478928B1 (ko) 2005-08-18
ATE242000T1 (de) 2003-06-15
US6165982A (en) 2000-12-26
EP0841065A2 (de) 1998-05-13

Similar Documents

Publication Publication Date Title
ATE242000T1 (de) Verwendung von sericin als antioxidantien und tyrosinase-inhibitoren
ES2106112T3 (es) Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
EP1159952A4 (de) Kosmetische zubereitungen
DE502004004659D1 (de) Verwendung von diphenylmethan-derivaten als tyrosinase-inhibitoren
AU2524692A (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
EA199800958A1 (ru) Композиция для предотвращения контактного дерматита, содержащая ее защитная пленка и способ предотвращения контактного дерматита
BR9811099A (pt) Inibidores de urocinase
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
ATE170868T1 (de) Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen
DE69317764D1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
ATE291424T1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
DE69717101D1 (de) VERWENDUNG VON alpha-ALKYLGLUCOSIDEN UND DEREN ESTERN ALS ANTIMIKROBIELLE EMULGATOREN
TWI256292B (en) Reduction inhibitory agent for active oxygen eliminating activity
ATE302613T1 (de) Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
MX9805290A (es) Utilizacion de inhibidores de la actividad del acido retinoico para tratar las pieles sensibles y/o los daños agudos inducidos por las radiaciones ultravioleta.
ATE409034T1 (de) Hautaufhellende mittel hydroxytetronsäure enthaltend
DE60219008D1 (de) Kosmetische und dermatologische zusammensetzung enthaltend n-acylaminoamid-derivate
ATE248581T1 (de) Kosmetische mittel
ATE214922T1 (de) Antioxydationwirkung von 3-dehydroshikimaten
BR9914895A (pt) Composições compreendendo uma mistura de bioflavonóis
DE69226171D1 (de) Zusammensetzung und verwendung von substituierten 1,3-dithiolo- und 1,4-dithiino-chinoxalinen als antimikrobielle mittel
ATE240313T1 (de) Tricyclische n-cyanoimine als inhibitoren der farnesyl-protein transferase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition